Abstract
A polyphenolic compound, 1,2,4,6-tetra-O-galloyl-β-D-glucose (1246TGG), was isolated from the traditional Chinese medicine Phyllanthus emblica L. (Euphorbiaceae) and assayed for its potential as an anti-hepatitis B virus (HBV) agent. The cytotoxicity of 1246TGG on HepG2.2.15 as well as HepG2 cells was determined by observing cytopathic effects, and the effects of 1246TGG on secretion of HBsAg and HBeAg in HepG2.2.15 cells were assayed by enzyme immunoassay. Results indicates that treatment with 1246TGG (6.25 μg/mL, 3.13 μg/mL), reduced both HBsAg and HBeAg levels in culture supernatant, yet the inhibitory effects tend to decline with the assay time. This study provides a basis for further investigation of the anti-HBV activity and possible mechanism of action of 1246TGG.
References
Duan D, Li Z, Luo H, et al. 2004. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease. Bioorg Med Chem Lett, 20; 14(24): 6041–6044.
EL-Mekkawy S, Meselhy M R, Kusumoto I T, et al. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo), 43(4): 641–648.
Fukuchi K, Sakagami H, Okuda T, et al. 1989. Inhibition of herpes simplex virus infection by tannins and related compounds. Antiviral Res, 11(5–6): 285–297.
Korba B E, Milman G. 1991. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res, 15(3): 217–228.
Lançon A, Delmas D, Osman H, et al. 2004. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun, 316(4): 1132–1137.
Lançon A, Hanet N, Jannin B, et al. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos, 35(5): 699–703.
Lee WM. 1997. Hepatitis B virus infection. N Engl J Med, 337(24): 1733–1745.
Lee S J, Lee H K, Jung M K, et al. 2006. In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose against hepatitis B virus. Biol Pharm Bull, 29(10): 2131–2134.
Manabu T, Masayuki T, Yasuo T. 1985. Studies on antiviral activity of several hydrolyzable tannins. International congress series (Herpes viruses virus chemother), 667: 223–224.
Nakashima H, Ichiyama K, Hirayama F, et al. 1996. Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice. Antiviral Res, 30(2–3): 95–108.
Sun J, Hou J L. 2010. Management of chronic hepatitis B: experience from China. J Viral Hepatitis, 17(S1): 10–17.
Tiollais P, Pourcel C, Dejean A. 1985. The hepatitis B virus. Nature, 317(5): 489–495.
Xia Q, Xiao P G, Wang L W, et al. 1997. Ethnopharmacology of Phyllanthus emblica L. China J Chin Mat Med, 22(9): 515–518. (in Chinese)
Xiang Y F, Pei Y, Wang Y F. 2008. Current status of natural products from plants as anti-herpes simplex virus 1 agents. Virol Sin, 23(5): 305–314.
Yeo S J, Yun Y J, Lyu M A, et al. 2002. Respiratory syncytial virus infection induces matrix metal-loproteinase-9 expression in epithelial cells. Arch Virol, 147(2):229–242.
Zhang J, Li L, Kim S H, et al. 2009. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm Res, 26(9): 2066–2080.
Zhang L, Wang G, Hou W, et al. 2010. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology, 51(2): 690–698.
Zhang Y J, Abe T, Tanaka T, et al. 2001. Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J Nat Prod, 64(12): 1527–1532.
Author information
Authors and Affiliations
Corresponding author
Additional information
Foundation item: Joint Funds of National Natural Science Foundation of China (U0632010).
Rights and permissions
About this article
Cite this article
Xiang, Yf., Ju, Hq., Li, S. et al. Effects of 1,2,4,6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture. Virol. Sin. 25, 375–380 (2010). https://doi.org/10.1007/s12250-010-3144-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-010-3144-y
Key words
- 1,2,4,6-tetra-O-galloyl-β-D-glucose (1246TGG)
- Phyllanthus emblica
- Euphorbiaceae
- HBV
- Antiviral agents